ABC of osteoporosis therapy. Which drugs for prevention and therapy?
Abstract
Medical Prevention and Therapy Fractures in the elderly, in particular of the proximal femur, may give rise to functional impairment with loss of independence and mobility. Apart from falls, the most common cause of fractures is osteoporosis or other impairments of mechanical stability of bone. In addition to the avoidance of falls and their sequelae, and the minimization of risk factors where possible, optimization of the mechanical stability of the bone is an important point of attack for interventional strategies. Current data on medical possibilities of osteoporosis prevention and treatment are presented and evidence for their effectiveness in reducing fractures discussed. Recommendations based on confirmed data are made, and possible future therapeutic approaches discussed.
Read the paper
Related studies
- Effectiveness of Bisphosphonates and Denosumab on Risk of Vertebral Fractures in Prostate Cancer Patients Under Androgen Deprivation Therapies: A Real-World Prospective Study
- Osteoporosis-related fractures after spinal cord injury: a retrospective study from Brazil
- Serum 25-hydroxyvitamin D, parathyroid hormone, and mortality in older men
- Lack of Association between Vitamin D Insufficiency and Cardiovascular or Fracture Risk: A UK Biobank Study
- Muscle strength and body composition are clinical indicators of osteoporosis
- Incidence of bone protection and associated fragility injuries in patients with proximal femur fractures
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.